Short Interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) Rises By 42.5%

Tiziana Life Sciences Ltd (NASDAQ:TLSA) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 808,600 shares, an increase of 42.5% from the February 28th total of 567,600 shares. Based on an average trading volume of 979,300 shares, the short-interest ratio is currently 0.8 days. Currently, 1.1% of the company’s shares are short sold.

Tiziana Life Sciences Stock Down 1.8 %

NASDAQ TLSA opened at $1.12 on Friday. Tiziana Life Sciences has a 1-year low of $0.41 and a 1-year high of $1.91. The stock has a 50-day moving average of $1.02 and a two-hundred day moving average of $0.94.

Institutional Investors Weigh In On Tiziana Life Sciences

Several large investors have recently added to or reduced their stakes in TLSA. Bison Wealth LLC purchased a new position in Tiziana Life Sciences in the 4th quarter valued at approximately $30,000. Zhang Financial LLC raised its stake in shares of Tiziana Life Sciences by 34.3% in the fourth quarter. Zhang Financial LLC now owns 93,187 shares of the company’s stock valued at $65,000 after acquiring an additional 23,800 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Tiziana Life Sciences by 12.4% in the fourth quarter. Geode Capital Management LLC now owns 245,722 shares of the company’s stock valued at $171,000 after purchasing an additional 27,041 shares during the period. Finally, Sanctuary Advisors LLC acquired a new position in Tiziana Life Sciences during the 3rd quarter worth $864,000.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.